Schmid KW - Search Results

1

[Molecular pathogenesis of thyroid tumors].

Tiedje V, Zwanziger D, Ting S, Schmid KW, Führer D. Tiedje V, et al. Among authors: schmid kw. Dtsch Med Wochenschr. 2015 Apr;140(8):578-82. doi: 10.1055/s-0041-101491. Epub 2015 Apr 7. Dtsch Med Wochenschr. 2015. PMID: 25850786 German.

2

[Medullary thyroid carcinoma].

Tiedje V, Ting S, Dralle H, Schmid KW, Führer D. Tiedje V, et al. Among authors: schmid kw. Internist (Berl). 2015 Sep;56(9):1019-31. doi: 10.1007/s00108-014-3638-z. Internist (Berl). 2015. PMID: 26338063 German.

3

[Molecular Pathogenesis of Thyroid Nodules: Relevance for Clinical Care].

Führer D, Musholt T, Schmid KW. Führer D, et al. Among authors: schmid kw. Laryngorhinootologie. 2017 Sep;96(9):590-596. doi: 10.1055/s-0043-109180. Epub 2017 Sep 7. Laryngorhinootologie. 2017. PMID: 28881369 Review. German.

4

Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status.

Broecker-Preuss M, Müller S, Britten M, Worm K, Schmid KW, Mann K, Fuhrer D. Broecker-Preuss M, et al. Among authors: schmid kw. BMC Cancer. 2015 Mar 26;15:184. doi: 10.1186/s12885-015-1186-0. BMC Cancer. 2015. PMID: 25879531 Free PMC article.

5

Prognostic markers and response to vandetanib therapy in sporadic medullary thyroid cancer patients.

Tiedje V, Ting S, Walter RF, Herold T, Worm K, Badziong J, Zwanziger D, Schmid KW, Führer D. Tiedje V, et al. Among authors: schmid kw. Eur J Endocrinol. 2016 Sep;175(3):173-80. doi: 10.1530/EJE-16-0252. Epub 2016 Jun 9. Eur J Endocrinol. 2016. PMID: 27283290

6

Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer.

Latteyer S, Tiedje V, König K, Ting S, Heukamp LC, Meder L, Schmid KW, Führer D, Moeller LC. Latteyer S, et al. Among authors: schmid kw. Endocrine. 2016 Dec;54(3):733-741. doi: 10.1007/s12020-016-1080-9. Epub 2016 Oct 1. Endocrine. 2016. PMID: 27696251

7

NGS based identification of mutational hotspots for targeted therapy in anaplastic thyroid carcinoma.

Tiedje V, Ting S, Herold T, Synoracki S, Latteyer S, Moeller LC, Zwanziger D, Stuschke M, Fuehrer D, Schmid KW. Tiedje V, et al. Among authors: schmid kw. Oncotarget. 2017 Jun 27;8(26):42613-42620. doi: 10.18632/oncotarget.17300. Oncotarget. 2017. PMID: 28489587 Free PMC article.

8

Differential regulation of monocarboxylate transporter 8 expression in thyroid cancer and hyperthyroidism.

Badziong J, Ting S, Synoracki S, Tiedje V, Brix K, Brabant G, Moeller LC, Schmid KW, Fuhrer D, Zwanziger D. Badziong J, et al. Among authors: schmid kw. Eur J Endocrinol. 2017 Sep;177(3):243-250. doi: 10.1530/EJE-17-0279. Epub 2017 Jun 2. Eur J Endocrinol. 2017. PMID: 28576880

9

[Diagnostic principles of thyroid tumors in pathology : Relevant changes due to the current WHO classification].

Theurer S, Rawitzer J, Ting S, Schmid KW. Theurer S, et al. Among authors: schmid kw. Pathologe. 2021 Feb;42(1):125-139. doi: 10.1007/s00292-020-00908-3. Pathologe. 2021. PMID: 33415346 German.

10

[Benign thyroid nodule or thyroid cancer?].

Führer D, Schmid KW. Führer D, et al. Among authors: schmid kw. Internist (Berl). 2010 May;51(5):611-9. doi: 10.1007/s00108-009-2500-1. Internist (Berl). 2010. PMID: 20405098 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

568 results

Search Page